NEW YORK (GenomeWeb News) – Luminex reported after the close of the market Monday that its second-quarter revenues grew 2 percent year over year, driven by a jump in instrument sales.

The Austin, Texas-based molecular diagnostics firm reported total revenues of $55.6 million for the three months ended June 30, compared to $54.3 million for the second quarter of 2012. It was slightly below analysts' consensus estimate for revenues of $55.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.